143 related articles for article (PubMed ID: 30939061)
1. Anti-Influenza A Virus Activities of Type I/III Interferons-Induced Mx1 GTPases from Different Mammalian Species.
Dam Van P; Desmecht D; Garigliany MM; Bui Tran Anh D; Van Laere AS
J Interferon Cytokine Res; 2019 May; 39(5):274-282. PubMed ID: 30939061
[TBL] [Abstract][Full Text] [Related]
2. Anti-Schmallenberg Virus Activities of Type I/III Interferons-Induced Mx1 GTPases from Different Mammalian Species.
Bayrou C; Van Laere AS; Dam Van P; Moula N; Garigliany MM; Desmecht D
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243140
[TBL] [Abstract][Full Text] [Related]
3. Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses.
Verhelst J; Spitaels J; Nürnberger C; De Vlieger D; Ysenbaert T; Staeheli P; Fiers W; Saelens X
J Virol; 2015 Nov; 89(21):10879-90. PubMed ID: 26292322
[TBL] [Abstract][Full Text] [Related]
4. The Antiviral Activity of Equine Mx1 against Thogoto Virus Is Determined by the Molecular Structure of Its Viral Specificity Region.
Wagner V; Sabachvili M; Bendl E; Fuchs J; Kochs G
J Virol; 2023 Feb; 97(2):e0193822. PubMed ID: 36749070
[TBL] [Abstract][Full Text] [Related]
5. Equine Mx1 Restricts Influenza A Virus Replication by Targeting at Distinct Site of its Nucleoprotein.
Fatima U; Zhang Z; Zhang H; Wang XF; Xu L; Chu X; Ji S; Wang X
Viruses; 2019 Dec; 11(12):. PubMed ID: 31810278
[TBL] [Abstract][Full Text] [Related]
6. Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses.
Fuchs J; Hölzer M; Schilling M; Patzina C; Schoen A; Hoenen T; Zimmer G; Marz M; Weber F; Müller MA; Kochs G
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490593
[TBL] [Abstract][Full Text] [Related]
7. Human/bovine chimeric MxA-like GTPases reveal a contribution of N-terminal domains to the magnitude of anti-influenza A activity.
Garigliany MM; Cornet A; Desmecht D
J Interferon Cytokine Res; 2012 Jul; 32(7):326-31. PubMed ID: 22686832
[TBL] [Abstract][Full Text] [Related]
8. Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.
Goujon C; Moncorgé O; Bauby H; Doyle T; Barclay WS; Malim MH
J Virol; 2014 Aug; 88(16):9017-26. PubMed ID: 24899177
[TBL] [Abstract][Full Text] [Related]
9. Mx proteins: GTPases involved in the interferon-induced antiviral state.
Pavlovic J; Schröder A; Blank A; Pitossi F; Staeheli P
Ciba Found Symp; 1993; 176():233-43; discussion 243-7. PubMed ID: 7507812
[TBL] [Abstract][Full Text] [Related]
10. Subcellular Localization of MxB Determines Its Antiviral Potential against Influenza A Virus.
Steiner F; Pavlovic J
J Virol; 2020 Oct; 94(22):. PubMed ID: 32907985
[TBL] [Abstract][Full Text] [Related]
11. Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection.
Dicks MD; Goujon C; Pollpeter D; Betancor G; Apolonia L; Bergeron JR; Malim MH
J Virol; 2016 Jan; 90(1):22-32. PubMed ID: 26446602
[TBL] [Abstract][Full Text] [Related]
12. Porcine Mx1 Protein Inhibits Classical Swine Fever Virus Replication by Targeting Nonstructural Protein NS5B.
Zhou J; Chen J; Zhang XM; Gao ZC; Liu CC; Zhang YN; Hou JX; Li ZY; Kan L; Li WL; Zhou B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343573
[TBL] [Abstract][Full Text] [Related]
13. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.
Riegger D; Hai R; Dornfeld D; Mänz B; Leyva-Grado V; Sánchez-Aparicio MT; Albrecht RA; Palese P; Haller O; Schwemmle M; García-Sastre A; Kochs G; Schmolke M
J Virol; 2015 Feb; 89(4):2241-52. PubMed ID: 25505067
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic characterization of interferon-induced antiviral GTPases murine Mx1 and human MxA proteins.
Melén K; Ronni T; Lotta T; Julkunen I
J Biol Chem; 1994 Jan; 269(3):2009-15. PubMed ID: 7507489
[TBL] [Abstract][Full Text] [Related]
15. Mx1 in Hematopoietic Cells Protects against Thogoto Virus Infection.
Spitaels J; Van Hoecke L; Roose K; Kochs G; Saelens X
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092574
[No Abstract] [Full Text] [Related]
16. Resistance to influenza virus infection of Mx transgenic mice expressing Mx protein under the control of two constitutive promoters.
Kolb E; Laine E; Strehler D; Staeheli P
J Virol; 1992 Mar; 66(3):1709-16. PubMed ID: 1371172
[TBL] [Abstract][Full Text] [Related]
17. Interferons, Mx genes, and resistance to influenza virus.
Horisberger MA
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 2):S67-71. PubMed ID: 7551417
[TBL] [Abstract][Full Text] [Related]
18. The viral nucleoprotein determines Mx sensitivity of influenza A viruses.
Zimmermann P; Mänz B; Haller O; Schwemmle M; Kochs G
J Virol; 2011 Aug; 85(16):8133-40. PubMed ID: 21680506
[TBL] [Abstract][Full Text] [Related]
19. Interferon-induced antiviral protein MxA interacts with the cellular RNA helicases UAP56 and URH49.
Wisskirchen C; Ludersdorfer TH; Müller DA; Moritz E; Pavlovic J
J Biol Chem; 2011 Oct; 286(40):34743-51. PubMed ID: 21859714
[TBL] [Abstract][Full Text] [Related]
20. Chemical-controlled Activation of Antiviral Myxovirus Resistance Protein 1.
Verhelst J; Van Hoecke L; Spitaels J; De Vlieger D; Kolpe A; Saelens X
J Biol Chem; 2017 Feb; 292(6):2226-2236. PubMed ID: 28011636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
